Loading chat...
MS HC50
Concurrent Resolution
Status
Failed
4/1/2023
Primary Sponsor
Rob Roberson
Click for details
AI Summary
- Urges the Centers for Disease Control and Prevention to include new RSV immunization technologies (vaccines and monoclonal antibodies) in the federal Vaccines for Children (VFC) program
- Identifies RSV as the leading cause of hospitalization among infants in the United States and the most common cause of bronchiolitis and pneumonia in children under one year old
- Notes that monoclonal antibodies for RSV show promise for preventative protection against the virus
- Specifies inclusion in VFC program should occur if the Advisory Committee on Immunization Practices recommends and the CDC Director approves such technologies
- Directs copies be sent to CDC Director Rochelle Walensky, CMS Administrator Chiquita Brooks-LaSure, HHS Secretary Xavier Becerra, and the Capitol Press Corps
Legislative Description
Respiratory syncytial virus; urge CDC to include in the Vaccines for Children program.
Last Action
Died In Committee
4/1/2023
Committee Referrals
Rules3/23/2023
Rules3/20/2023
Full Bill Text
No bill text available